UK MDA (Medical Devices Agency) warns of respiratory device misassembly:
This article was originally published in Clinica
The UK Medical Devices Agency (MDA) has renewed warnings of the danger of using misassembled endotracheal and tracheostomy tubes, in light of "an increasing number of reports of barotrauma". In a hazard notice issued last week, the MDA urges that whenever respiratory therapy devices are connected to endotracheal or tracheostomy tubes, staff ensure there is free passage of expired gases and that assembly be undertaken only by appropriately trained staff. The agency reports two new related incidents, with "serious consequences". In one case, a disposable nebuliser chamber was connected directly onto the patient's tracheal tube. In the other, an oxygen therapy connector was connected to a breathing system filter, directly attached to the patient's endotracheal tube. Incorrectly assembling a respiratory therapy device to a tight-fitting facemask poses similar hazards.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.